Return to Article Details
Pharmacoeconomics Assessment of cost-effectiveness for the treatment of Community-Acquired Pneumonia and Chronic Bronchitis Exacerbations with gemifloxacin in patients attended at the Instituto Mexicano del Seguro Social
Download
Download PDF